Not sure what you meant by, "What do they know". Since the OS is 14 months for standard care, do we really expect to get any trial results released soon on Ovarian and if so, will it contain anything worth while like OS?
They have released so little survival data that it is difficult to guess when they will time the release. They might have 20 patients that have been on study for more than 14 months. It is very strange that they have moved the end out so far. The only explanation I can imagine is the OS is trending toward greater than two years.